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LETTERS TO THE EDITOR
Regarding “No evidence of a gender difference in
carotid blood velocities across stenoses”
Comerota et al1 reported significantly higher blood flow ve-
locities in women across stenoses of 55% to 75% of the internal
carotid artery (ICA) than in men. Given the law of conservation of
mass, it is difficult to understand how a given percentage of luminal
narrowing can cause a different increase in velocity across genders.
Comerota et al used a small sample size (40 in each group),
neglected to use an appropriate correction for multiple compari-
sons, such as the Bonferroni correction, and did not report statis-
tics for age (a potential confound) in the groups where the signif-
icant differences were found.
The John Hunter Hospital Cardiovascular Unit database was
queried for all carotid duplex studies since the inception of the
database in 1991. The analysis included 6,165 studies comprising
3,287 men and 2,878 women. Student’s t test for independent
samples was used to determine if there was an effect of gender on
carotid artery blood flow velocities in both ICA and common
carotid artery (CCA) on the left and right. Because of the number
of comparisons being made, a Bonferroni correction was used, and
a result of P  .004 was considered significant. With this sample
size, assuming a statistical power of 0.8, a mean difference of 0.06
m/s in the ICA would be detectable at the level of P  0.004.
Comerota et al found a mean difference of 0.49 m/s.
In our dataset, women had significantly lower CCA velocities
than men (left side: t  5.327, df[6163], P  .0001; right side: t
 4.646, df[6179], P  .0001). Furthermore, females were an
average of 2 years older than their male counterparts (t –6.583,
df[6228], P .0001). Age was significantly correlated with veloc-
ities of the CCA (r  –.295, P  .0001) and the ICA (r  –.048,
P  .0001). This confound may account for the 0.03-m/s differ-
ence found in both the right and left CCA velocities between men
and women.
Comerota et al found a gender difference at 50% and 60%
stenosis. The arteries where a 50% to 79% stenosis was found on
duplex were extracted from the group as a whole and compared
across genders for both the right and left sides. This gave a sample
size of 202men and 174 women with right-sided stenoses and 382
men and 336 women with left-sided stenoses. No significant
differences in velocities were found for either the left or the right
common or internal carotid arteries in this group.
A 2 analysis, performed using gender and category of steno-
sis, found that men are significantly more likely to have moderate
and severe disease than women (right side: 2 12.134, P .001;
left side: 2  13.235, P  .001.
In conclusion, there is no evidence of a gender difference in
blood flow velocities across stenoses in our relatively large dataset.
The findings of Comerota et al may be confounded by an effect of
age differences.
Neva Jane Bull, BSc, DMU(Vasc)
Cardiovascular Department
John Hunter Hospital, Newcastle, NSW, Australia
REFERENCE
1. Comerota, AJ, Salles-Cunha SX, Daoud Y, Jones L, Beebe HG. Gender
differences in blood velocities across carotid stenoses. J Vasc Surg 2004;
40:939-44.
doi:10.1016/j.jvs.2005.01.051
Regarding “Gender differences in blood velocities
across carotid stenoses”
I read with interest the comments of the John Hunter Hospi-
tal Cardiovascular Unit’s description of their database on carotid
duplex findings. They have a large experience that I am sure is
comparable to most others. Most large centers that performed an
analysis as they have would derive the same conclusions, namely
that there are no differences in findings in women compared with
men. Because of analyses like these, which compare only one
duplex examination with another, gender differences have failed to
be appreciated.
The rigor of the method described in their report requires
emphasis, since the difference between our methods of analysis is
likely the reason for the difference in our observations and conclu-
sions. The gender difference study reviewed a database of 938
carotid arteriograms with accompanying carotid duplex examina-
tions that were independently interpreted. The arteriograms were
then listed by decile of disease with the corresponding carotid
duplex finding. Results for men and women were analyzed. To
completely avoid bias, only the most severely diseased artery was
studied for each patient.
After this analysis, it was evident that women had higher
velocities than men for similar degrees of arteriographic stenosis,
especially at the clinically relevant thresholds of disease. There are
numerous reasons for this finding, which we attempted to eluci-
date in the discussion.
I appreciate the work performed by the John Hunter Hospital
Cardiovascular Unit; however, to challenge our observations, I
believe a study that used the same methods would be required. I
would encourage them to do so and look forward to the results.
Anthony J. Comerota, MD
Jobst Vascular Center
Toledo, Ohio
doi:10.1016/j.jvs.2005.02.015
Regarding “Aortobifemoral graft infection with
Mycobacterium tuberculosis: Treatment with abscess
drainage, debridement, and long-term administration
of antibiotic agents”
The case report by Raffetto et al (J Vasc Surg 2004;40:826-
829) describing the treatment of an aortobifemoral graft infected
with tuberculosis raises but does not address a longstanding unan-
swered question about the etiology of Takayasu arteritis. For
decades, an association between Takayasu arteritis and tuberculosis
has been noted. There is a school of thought holding that Takayasu
arteritis may be caused or triggered byMycobacterium tuberculosis.
Many studies from the 1960s and 1970s showed a much higher
incidence of tuberculosis in subjects with Takayasu arteritis than in
the general population. For example, in an autopsy series of 20
patients with Takayasu arteritis in India, Kinare found active tu-
berculosis in 60%, vs 10% in routine necropsy cases in the region.1
I have come across two such cases in my own practice. One of these
was an Asian female exchange student presenting synchronously
with scrofula and Takayasu arteritis. Immunology studies have
shown that patients with Takayasu arteritis have a heightened
immune response to various tuberculous antigens, and there are
case reports of Takayasu arteritis resolving with treatment of con-
comitant active tuberculosis.2-4 Finally, in the case described,
tuberculosis almost certainly was reactivated in response to treat-
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ment of her arteritis with antitumor necrosis factor-. Antitumor
necrosis factor- inhibits granuloma formation, and there are
many reports of tuberculosis after its use.5-6
As is the case with most vasculitides, the etiology of Takayasu
arteritis is not known. There is considerable overlap with other
syndromes of large-vessel arteritis. Not all evidence points toward
tuberculosis as a cause, and other pathophysiologic mechanisms
have been proposed. Nevertheless, the association between Taka-
yasu arteritis and Mycobacterium tuberculosis is an intriguing one
and awaits further study.
Ian R. McPhail, MD
Cardiovascular Diseases and Interventional Radiology
Mayo Clinic
Rochester, Minn
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Reply
I thank Dr McPhail for his insightful and interesting com-
ments. I would certainly agree with him that we did not address the
etiology of Takayasu’s arteritis. The focus of the case report was to
describe a rare form of graft infection by Mycobacterium tubercu-
losis and its successful treatment as well as briefly summarize the
bacterial etiology and treatment of aortic graft infections in gen-
eral. It was not our intention to discuss the association of Takaya-
su’s arteritis with M. tuberculosis.
Dr McPhail has raised some very interesting issues about the
etiology of Takayasu’s arteritis and the possible connection with
tuberculosis. Of course there is a challenge in trying to attribute
causation (as with Crohn’s disease or sarcoidosis) as opposed to
association. The association between Takayasu’s arteritis and tu-
berculosis has been noted and is well referenced by Dr. McPhail.
But one third of the world’s population is infected with tubercu-
losis (World Health Organization), and that number is much
higher in India and similar places. Again, the association does not
ascribe causality: the same immune defect that causes the arteritis
may permit activation of latent tuberculosis infection.
To the best of our knowledge M. tuberculosis antigens have
not been found in the arterial wall of patients with Takayasu’s
arteritis or other vasculitides. We certainly agree with Dr McPhail
and the references provided that in the case we have described, the
patient’s quiescent tuberculosis was reactivated by infliximab
(Remicade, Centiocor, Inc, Malvern, Pa), an anti-tumor necrosis
factor- monoclonal antibody.
Joseph D. Raffetto, MD
VA Boston Healthcare System
West Roxbury, Mass
doi:10.1016/j.jvs.2005.02.016
Regarding “Ultrasound findings after radiofrequency
ablation of the great saphenous vein”
Wewould like to comment on the article by Salles-Cunha et al:
Ultrasound findings after radiofrequency ablation of the great
saphenous vein: Descriptive analysis (J Vasc Surg 2004;40:1166-
1173). The development of the radiofrequency (RF) closure tech-
nique for treating the incompetent great saphenous vein (GSV)
was completed by multiple specialties, with dermatology taking a
significant role.1,2 Dermatologic surgeons were the first to apply
tumescence to ambulatory phlebectomy and/or ligation of the
GSV and its tributaries.3,4 We therefore used tumescent anesthesia
with radiofrequency or other energies for endoluminal closure/
ablation of the GSV. Tumescent anesthesia or the placement of
large volumes of dilute anesthesia in a perivascular position serves
several purposes: first, to protect perivascular tissues from the
thermal effects of intravascular energy such as RF; second, to
decrease the diameter of the treated vein to allow for better contact
of the RF electrodes with the vein wall, and thus secondarily to
reduce intravascular blood for nonspecific coagulation; and third,
to provide better and safer anesthesia for patients. All of these
effects should serve to reduce perivascular inflammation.
Our initial results showed that tumescent anesthesia to treat
the GSV with endovenous techniques resulted in a painless proce-
dure with little down-time and immediate ambulation of the
patient.1,2,5,6 Regarding RF closure, we now have up to 5 years of
follow-up on 125 (M.P.G.) and 627 (R.A.W.) patients. We also
have treated patients with intravascular lasers, including the
810-nm diode laser, with up to 3 years of follow-up (75 patients,
M.P.G.; 36 patients, R.A.W.), and an additional 143 patients with
the 1,320-nm intravascular neodymium:yttrium-aluminum-garnet
laser with up to 2 years of follow-up (43 patients, M.P.G.; 121
patients, R.A.W.).7 Our combined clinical experience with en-
dovenous techniques spans 5.5 years, with well over 1,000 patient
treatments. Posttreatment duplex evaluation data at regular time
intervals exists on the vast majority of these patients.
Contrary to what is reported by Salles-Cunha et al, our expe-
rience with tumescent anesthesia used in every one of our patients
is a complete lack of small-vessel networks when patients are
evaluated postoperatively with duplex ultrasound. We believe that
the reason for our failure to find small-vessel networks is not a lack
of trying to see them but rather the minimization of inflammation
that occurs with tumescent anesthesia placed in the perivascular
space during either RF or laser endothelial ablation.
We have not performed ligation of the saphenofemoral junc-
tion (SFJ) on any of our over 1,000 patients and question the
accuracy of the findings of Salles-Cunha et al, who found a de-
creased incidence of small-vessel networks in patients whose SFJs
were ligated. We suspect that the small number of patients who
were treated without ligation of the SFJ (13) vs the 93 patients
who did have SFJ ligation produced the false statistical significance
of this finding. Alternatively, if inflammation is the most likely
cause for small vessel networks, why would ligation decrease the
extent or time of inflammation?
Finally, the investigators admit to performing ligation of all
tributary veins at the time of ligation at the SFJ. Could it be
possible that ligating and disrupting the normal vascular system at
the SFJ results in a decrease in the normal number of small-vessel
networks and that this accounts for the decrease seen in patients
operated on vs patients in whom only the RF is performed?
We are curious about why none of the five studies that we
published were not cited in the Salles-Cunha et al publica-
tion.1,2,5-7 We support efforts to share information across special-
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